|
1.
|
Cahill BA and Braccia D: Current treatment
for hepatocellular carcinoma. Clin J Oncol Nurs. 8:393–399. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
3.
|
Lee RC, Feinbaum RL and Ambros V: The
C. Elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
|
|
4.
|
Ruvkun G: Molecular biology: glimpses of a
tiny RNA world. Science. 294:797–799. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Ji J, Shi J, Budhu A, et al: MicroRNA
expression, survival, and response to interferon in liver cancer. N
Engl J Med. 361:1437–1447. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential
human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Chang HM and Paul But PH: Pharmacology and
Applications of Chinese Materia Medica. World Scientific
Publishing; Singapore: pp. 1061–1077. 2001
|
|
8.
|
Kim HY, Shin HS, Park H, Kim YC, Yun YG,
Park S, Shin HJ and Kim K: In vitro inhibition of coronavirus
replications by the traditionally used medicinal herbal extracts,
Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma and
Phellodendron cortex. J Clin Virol. 41:122–128. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Ye X, Feng Y, Tong Y, Ng KM, Tsao S, Lau
GK, Sze C, Zhang Y, Tang J, Shen J and Kobayashi S:
Hepatoprotective effects of Coptidis rhizoma aqueous extract
on carbon tetrachloride-induced acute liver hepatotoxicity in rats.
J Ethnopharmacol. 124:130–136. 2009.
|
|
10.
|
Tang J, Feng Y, Tsao S, Wang N, Curtain R
and Wang Y: Berberine and Coptidis rhizoma as novel
antineoplastic agents: a review of traditional use and biomedical
investigations. J Ethnopharmacol. 126:5–17. 2009.
|
|
11.
|
Tsang CM, Lau EP, Di K, Cheung PY, Hau PM,
Ching YP, Wong YC, Cheung AL, Wan TS, Tong Y, Tsao SW and Feng Y:
Berberine inhibits Rho GTPases and cell migration at low doses but
induces G2 arrest and apoptosis at high doses in human cancer
cells. Int J Mol Med. 24:131–138. 2009.PubMed/NCBI
|
|
12.
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Li Y, Zhu X, Gu J, Dong D, Yao J, Lin C,
Huang K and Fei J: Anti-miR-21 oligonucleotide sensitizes leukemic
K562 cells to arsenic trioxide by inducing apoptosis. Cancer Sci.
101:948–954. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu
H, Liu MF and Wang ED: MicroRNA-155 functions as an oncomiR in
breast cancer by targeting the suppressor of cytokine signaling 1
gene. Cancer Res. 70:3119–3127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Sun Y, Bai Y, Zhang F, Wang Y, Guo Y and
Guo L: miR-126 inhibits non-small cell lung cancer cell
proliferation by targeting EGFL7. Biochem Biophys Res Commun.
391:1483–1489. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Bhattacharya R, Nicoloso M, Arvizo R, Wang
E, Cortez A, Rossi S, Calin GA and Mukherjee P: MiR-15a and MiR-16
control Bmi-1 expression in ovarian cancer. Cancer Res.
69:9090–9095. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Bhattacharyya SN, Habermacher R, Martine
U, Closs EI and Filipowicz W: Relief of microRNA-mediated
translational repression in human cells subjected to stress. Cell.
125:1111–1124. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Feng Y, Cheung KF, Wang N, Liu P,
Nagamatsu T and Tong Y: Chinese medicines as a resource for liver
fibrosis treatment. Chin Med. 4:162009.PubMed/NCBI
|
|
19.
|
Cragg GM and Newman DJ: Plants as a source
of anti-cancer agents. J Ethnopharmacol. 100:72–79. 2005.PubMed/NCBI
|
|
20.
|
Yang LQ, Singh M, Yap EH, Ng GC, Xu HX and
Sim KY: In vitro response of Blastocystis hominis against
traditional Chinese medicine. J Ethnopharmacol. 55:35–42. 1996.
|
|
21.
|
Feng Y, Luo WQ and Zhu SQ: Explore new
clinical application of Huanglian and corresponding compound
prescriptions from their traditional use. Zhongguo Zhong Yao Za
Zhi. 33:1221–1225. 2008.PubMed/NCBI
|
|
22.
|
Luo WQ, Hui SC, Chan TY and Feng Y:
Inhibitory effect of water extract from golden thread (Huanglian)
on leukemia L-1210 cells cultured in vitro. Pharmacologist.
44:1262002.
|
|
23.
|
Gao P, Tchernyshyov I, Chang TC, Lee YS,
Kita K, Ochi T, Zeller KI, De Marzo AM, van Eyk JE, Mendell JT and
Dang CV: c-Myc suppression of miR-23a/b enhances mitochondrial
glutaminase expression and glutamine metabolism. Nature.
458:762–765. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Yan LX, Huang XF, Shao Q, Huang MY, Deng
L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in
human breast cancer is associated with advanced clinical stage,
lymph node metastasis and patient poor prognosis. RNA.
14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Sun M, Estrov Z, Ji Y, Coombes KR, Harris
DH and Kurzrock R: Curcumin (diferuloylmethane) alters the
expression profiles of microRNAs in human pancreatic cancer cells.
Mol Cancer Ther. 7:464–473. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Li Y and Sarkar FH: Down-regulation of
invasion and angiogenesis-related genes identified by cDNA
microarray analysis of PC3 prostate cancer cells treated with
genistein. Cancer Lett. 186:157–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Garikapaty VP, Ashok BT, Tadi K, Mittelman
A and Tiwari RK: 3,3′-Diindolylmethane downregulates pro-survival
pathway in hormone independent prostate cancer. Biochem Biophys Res
Commun. 340:718–725. 2006.
|
|
28.
|
Katiyar SK, Afaq F, Perez A and Mukhtar H:
Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of
human skin inhibits ultraviolet radiation-induced oxidative stress.
Carcinogenesis. 22:287–294. 2001. View Article : Google Scholar
|
|
29.
|
Kundu JK and Surh YJ: Cancer
chemopreventive and therapeutic potential of resveratrol:
mechanistic perspectives. Cancer Lett. 269:243–261. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Papagiannakopoulos T, Shapiro A and Kosik
KS: MicroRNA-21 targets a network of key tumor-suppressive pathways
in glioblastoma cells. Cancer Res. 68:8164–8172. 2008. View Article : Google Scholar : PubMed/NCBI
|
